Steroids for Preterm Birth | Supporting Tiny Beginnings

Navigating pregnancy brings a unique blend of excitement and anticipation, often accompanied by a deep desire to ensure the best possible start for your baby. When the possibility of preterm birth arises, it can understandably bring a wave of concern, but there are medical advancements designed to support these earliest arrivals.

One such intervention, antenatal corticosteroids, plays a significant role in preparing a baby for an early arrival. Understanding this treatment can bring a sense of clarity and reassurance during a challenging time.

What Are Antenatal Corticosteroids?

Antenatal corticosteroids are a class of medications, specifically synthetic glucocorticoids, given to pregnant individuals when there’s a risk of delivering early. These medications are not the same as anabolic steroids sometimes associated with athletic performance; rather, they are designed to mimic natural hormones that help a baby’s development.

Their primary purpose is to accelerate the maturation of the fetal lungs. Preterm babies often face respiratory challenges because their lungs haven’t fully developed the necessary components to breathe effectively outside the womb.

The medications work by stimulating the production of surfactant, a crucial substance that coats the air sacs (alveoli) in the lungs. Surfactant prevents these air sacs from collapsing, making it easier for the baby to breathe once born. Without adequate surfactant, a baby can develop respiratory distress syndrome (RDS), a serious condition for preterm infants.

Steroids for Preterm Birth: The Protective Mechanism

The administration of steroids for preterm birth primarily targets the developing fetal lungs, but their benefits extend beyond just respiratory support. The protective mechanism involves several key physiological changes within the fetus.

The steroids cross the placenta and act directly on fetal cells, particularly those in the lungs. They promote the differentiation of type II pneumocytes, the cells responsible for producing surfactant. This accelerated maturation helps ensure that even if born early, the baby’s lungs are better equipped to function.

Beyond lung maturation, antenatal corticosteroids also contribute to reducing the risk of other severe complications common in preterm infants. These include a decreased incidence of intraventricular hemorrhage (IVH), which is bleeding into the brain’s ventricles, and necrotizing enterocolitis (NEC), a serious intestinal condition. The exact mechanisms for these additional benefits are still being researched but are thought to involve improved vascular stability and anti-inflammatory effects.

Who Benefits from Antenatal Corticosteroids?

Antenatal corticosteroids are a targeted intervention, recommended for specific situations where the benefits significantly outweigh any potential risks. The primary candidates are pregnant individuals at risk of preterm birth within the next seven days.

Current guidelines, such as those from the American College of Obstetricians and Gynecologists (ACOG), recommend a single course of antenatal corticosteroids for pregnant individuals between 24 weeks and 34 weeks and 6 days of gestation who are at risk of preterm delivery within seven days. This gestational age window is where the intervention has shown the most significant benefit in reducing neonatal morbidity and mortality.

In some specific cases, a single course may also be considered for those at 23 weeks of gestation or between 34 weeks and 36 weeks and 6 days, particularly if they have not previously received corticosteroids and are at imminent risk of preterm birth. Contraindications are rare but include situations where the mother has a systemic infection that could be worsened by steroids, though the benefits often still outweigh these concerns.

Indications for Treatment

• Threatened preterm labor (contractions with cervical change).
• Preterm premature rupture of membranes (PPROM).
• Multiple gestation with risk of preterm delivery.
• Medical conditions necessitating early delivery (e.g., severe preeclampsia, placental abruption).

When Treatment is Not Typically Indicated

• Term pregnancy (37 weeks or later).
• No risk of preterm birth within the next seven days.
• Maternal conditions that would make steroid administration unsafe (rare).

Gestational Age Guidelines for Antenatal Corticosteroids

Gestational Age	Recommendation	Rationale
Before 23 weeks	Not routinely recommended	Limited evidence of benefit, higher risks.
24 weeks to 34 weeks 6 days	Strongly recommended	Significant reduction in RDS, IVH, NEC, and mortality.
34 weeks to 36 weeks 6 days	Considered in specific cases	May be beneficial if no prior course and imminent risk.

The Administration Process

Administering antenatal corticosteroids is a straightforward process, typically involving specific types of steroids and a defined dosage regimen. The most commonly used medications are betamethasone and dexamethasone, both of which are effective and cross the placenta well.

For betamethasone, the standard regimen involves two doses of 12 mg each, given intramuscularly 24 hours apart. For dexamethasone, the regimen is four doses of 6 mg each, given intramuscularly every 12 hours. Both regimens aim to deliver a full course of treatment within a 24-48 hour window, allowing the medication to take effect.

The full benefits of the corticosteroids are typically seen starting 24 hours after the first dose and peaking 48 hours after the completion of the course. These benefits generally last for about seven days. If the risk of preterm birth persists beyond this period, a “rescue course” or repeat course might be considered, though this is approached with caution due to potential cumulative effects.

Potential Side Effects and Considerations

While antenatal corticosteroids offer substantial benefits, it’s natural to consider any potential side effects. The good news is that for a single course of treatment, serious adverse effects are uncommon for both the mother and the baby.

For the Mother

• Transient Hyperglycemia: A temporary increase in blood sugar levels is common. This is usually mild and resolves on its own, but it requires monitoring, especially for those with gestational diabetes.
• Increased White Blood Cell Count: A temporary elevation in white blood cells can occur, which is a normal physiological response to steroids and not indicative of infection.
• Fluid Retention: Some individuals may experience mild fluid retention.

For the Baby

• Transient Decrease in Fetal Breathing Movements: Babies may show a temporary decrease in fetal breathing movements on ultrasound, which typically resolves within 48 hours.
• Slightly Reduced Birth Weight: Some studies have noted a small, transient reduction in birth weight, though this is generally not clinically significant in the long term with a single course.
• No Significant Long-Term Neurodevelopmental Impairment: Extensive research, including guidelines from the American Academy of Pediatrics (AAP), confirms that a single course of antenatal corticosteroids does not cause adverse long-term neurodevelopmental outcomes.

The discussion around repeated courses of corticosteroids is more nuanced. While a single course is well-established as safe and effective, multiple or rescue courses are used more selectively. Concerns about potential effects on fetal growth or neurodevelopment with repeated exposure have led to cautious recommendations, typically reserving repeat courses for individuals still at high risk of preterm birth more than seven days after the initial course, and only after careful consideration of risks and benefits.

Commonly Used Antenatal Corticosteroids

Medication	Dosage Regimen	Route
Betamethasone	12 mg every 24 hours for 2 doses	Intramuscular
Dexamethasone	6 mg every 12 hours for 4 doses	Intramuscular

Guidelines and Recommendations

Medical organizations worldwide have established clear guidelines for the use of antenatal corticosteroids, emphasizing their importance in improving outcomes for preterm infants. These guidelines are regularly updated based on the latest research to ensure the safest and most effective practices.

Key recommendations consistently highlight the use of a single course of corticosteroids for individuals at risk of preterm birth within the appropriate gestational age window. This approach balances the significant benefits of lung maturation with minimizing potential risks associated with steroid exposure.

The concept of a “rescue course” or repeat course is also addressed in guidelines. A rescue course might be considered if more than seven days have passed since the initial course, and the individual remains at high risk of preterm birth. However, this decision is made on a case-by-case basis, weighing the continued risk of preterm delivery against the potential for cumulative effects of steroids. Shared decision-making between the pregnant individual and their healthcare team is paramount, ensuring all concerns are addressed and the chosen path aligns with individual circumstances and values.

The Impact on Preterm Infants’ Outcomes

The introduction of antenatal corticosteroids has profoundly impacted the survival and health outcomes of preterm infants. This intervention is considered one of the most significant advancements in perinatal medicine.

Studies consistently demonstrate a substantial reduction in neonatal mortality among infants exposed to antenatal corticosteroids. The most dramatic effect is seen in the reduction of respiratory distress syndrome (RDS), the leading cause of morbidity and mortality in preterm babies. Corticosteroids can reduce the incidence of RDS by approximately 30-50%.

Beyond RDS, the impact extends to other critical areas. There’s a notable decrease in the severity and incidence of intraventricular hemorrhage (IVH), a serious brain bleed, and necrotizing enterocolitis (NEC), a severe intestinal condition. These reductions in severe complications contribute to improved overall health and quality of life for preterm survivors.

Regarding long-term neurodevelopmental outcomes, a single course of antenatal corticosteroids has been shown to be either neutral or beneficial. Babies who receive this treatment generally have better or comparable neurodevelopmental outcomes compared to those who do not, primarily because the prevention of severe complications like IVH protects brain development.